Riyadh - Sharikat Mubasher: The Global Health Exhibition 2024 kicked off today in Riyadh with the participation of over 1,200 exhibiting brands from more than 40 countries.

Throughout three days, the forum is expected to witness the launch of investment projects worth more than SAR 50 billion.

The first day of the forum witnessed the announcement of Dr. Salman Al Habib Medical Group to invest over SAR 10 billion in developing and operating several prominent healthcare projects.

The Saudi Ministry of Health and the Ministry of Investment also concluded an agreement worth over SAR 7 billion with Virtus Health Partners to establish Jabal Al-Noor Medical City for investments in an educational hospital, medical colleges, and health care research.

Dr. Salman Faqeeh Hospital pledged investments worth SAR 5 billion to fuel its expansions in Jeddah, Makkah, Madinah, and Riyadh for both existing and new hospitals.

Further, Dallah Health revealed its plans to invest SAR 4 billion to acquire two hospitals in the Eastern region, build a new hospital in the North of Riyadh, open new clinics across the capital city, and broaden its existing facilities in Riyadh and Makkah.

Boston Oncology, an innovative biogenerics company, also signed a contract worth SAR 3 billion with King Fahad Medical City to localize the CAR-T Cell Program.

Moreover, the Almoosa Health Group revealed investing SAR 3 billion to establish five primary care centers, two hospitals, and a university.

The Saudi National Housing Company (NHC) signed a cooperation agreement with Health Holding to provide housing facilities and offers for the health company.

Finally, the National Unified Procurement Company (NUPCO) unveiled two final offtake agreements with Sanofi and Nova Nordisk to localize the manufacturing of a few types of insulin in the Kingdom. 

It should be noted that the Global Health Exhibition places a key focus on the integration of novel artificial intelligence (AI) into mainstream healthcare delivery and its power to transform the patient journey from diagnostics to outcomes